Many genes of the cytochrome P450 3A (CYP3A) subfamily, including several human and rat isoforms, are inducible by glucocorticoids. In the rat CYP3A23 gene, a 110-base pair segment of the proximal 5-flanking region mediates dexamethasone activation. Three binding sites (DexRE-1, DexRE-2, and Site A), identified by DNase I footprinting analysis, were characterized for their relative contribution to both basal activity and dexamethasone inducibility. Site-directed mutagenesis of DexRE-1 (؊144 to ؊169) and DexRE-2 (؊118 to ؊136) demonstrated that each contained a core imperfect AGGTCA direct repeat, which comprised a consensus nuclear receptor binding site, and was essential for dexamethasone responsiveness but was not required for basal activity. Competition gel shift and supershift analyses revealed that both sites can bind the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor.Site A (؊85 to ؊110) was shown to be important for both basal activity and dexamethasone responsiveness. Point mutants displayed a reduced (2-3-fold) induction response, compared with 15-fold for wild-type, which was accompanied by a 40 -60% drop in basal activity. Site A was shown to bind the liver-enriched nuclear receptor hepatocyte nuclear factor 4. Our studies demonstrate that the mechanism mediating glucocorticoidinducible transcriptional activity of CYP3A23 involves multiple binding sites for members of the nuclear receptor superfamily.The cytochrome P450s (CYPs) 1 make up a superfamily of heme-containing monooxygenases that are found most abundantly in liver endoplasmic reticulum and catalyze the oxidation or reduction of both endogenous and foreign substrates, often as an essential step in their elimination (1). CYP expression is modulated by endogenous and exogenous compounds, which may reflect a homeostatic mechanism whereby normal "endogenous ligand" concentrations are maintained. In early studies, steroids were shown to regulate expression of a cytochrome P450 family that was distinct from the 3-methylcholanthrene or phenobarbital inducible P450s (2-5). Pregnenolone 16␣-carbonitrile (PCN) was characterized as the prototypical inducer of the CYP3A family; however, many glucocorticoids have been shown to be more potent than PCN, whereas certain non-glucocorticoids, such as phenobarbital and macrolide antibiotics, also induce the same protein (6 -8). CYP3A proteins have been identified in several species, including rat, rabbit, mouse, and human (9 -14). The major glucocorticoid-responsive CYP3A gene in rat is 3A23, whereas 3A4 and 3A5 are inducible forms in human (15, 16). CYP3A enzymes metabolize over 60% of therapeutically relevant compounds and are involved in 6-hydroxylation of the endogenous steroids testosterone, progesterone, and cortisol (17-19).Regulation of rat 3A genes CYP3A23 and 3A2 has been the most extensively characterized. CYP3A2 is the form expressed in uninduced animals; however, its expression displays a gender and developmental stage-dependent pattern (8, 20 -22). Despite its hi...